In the past week, MED stock has gone up by 6.70%, with a monthly gain of 1.14% and a quarterly surge of 0.21%. The volatility ratio for the week is 3.18%, and the volatility levels for the last 30 days are 3.56% for Medifast Inc The simple moving average for the last 20 days is 5.53% for MED stock, with a simple moving average of -11.50% for the last 200 days.
Is It Worth Investing in Medifast Inc (NYSE: MED) Right Now?
Additionally, the 36-month beta value for MED is 0.89. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
The public float for MED is 10.54M and currently, short sellers hold a 12.62% ratio of that float. The average trading volume of MED on June 19, 2025 was 226.01K shares.
MED) stock’s latest price update
The stock of Medifast Inc (NYSE: MED) has increased by 5.04 when compared to last closing price of 13.49. Despite this, the company has experienced a 6.70% gain in its stock price over the last five trading sessions. zacks.com reported 2025-05-28 that Medifast (MED) reported earnings 30 days ago. What’s next for the stock?
Analysts’ Opinion of MED
Many brokerage firms have already submitted their reports for MED stocks, with DA Davidson repeating the rating for MED by listing it as a “Neutral.” The predicted price for MED in the upcoming period, according to DA Davidson is $17 based on the research report published on November 05, 2024 of the previous year 2024.
DA Davidson, on the other hand, stated in their research note that they expect to see MED reach a price target of $17.50, previously predicting the price at $25. The rating they have provided for MED stocks is “Underperform” according to the report published on June 05th, 2024.
Stephens gave a rating of “Equal-Weight” to MED, setting the target price at $82 in the report published on October 13th of the previous year.
MED Trading at 8.43% from the 50-Day Moving Average
After a stumble in the market that brought MED to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -37.45% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MED starting from Chard Daniel R, who purchase 381 shares at the price of $13.13 back on Jun 13 ’25. After this action, Chard Daniel R now owns 149,698 shares of Medifast Inc, valued at $5,003 using the latest closing price.
Stock Fundamentals for MED
Current profitability levels for the company are sitting at:
- -0.01 for the present operating margin
- 0.74 for the gross margin
The net margin for Medifast Inc stands at -0.01. The total capital return value is set at -0.03. Equity return is now at value -3.32, with -2.40 for asset returns.
Based on Medifast Inc (MED), the company’s capital structure generated 0.06 points at debt to capital in total, while cash flow to debt ratio is standing at 1.41.
Currently, EBITDA for the company is 15.59 million with net debt to EBITDA at -12.04. When we switch over and look at the enterprise to sales, we see a ratio of 0.14. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.52.
Conclusion
In conclusion, Medifast Inc (MED) has seen mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
